Sanjay Sehgal

B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.

Teleperformance Ltd. provides contact center and CRM solutions. It offers its clients inbound and outbound teleservices, customer service, CRM customer acquisition, and payment processing services. The firm has contact centers in Bristol, Birmingham, Bangor and Ashby. The company was founded in 1950 and is headquartered in Bristol, the United Kingdom.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Northern Crest Investments Ltd. provides residential property solutions. It creates and licenses intellectual property to third party acquirers and distributors of property. The firm operates through two segments: Financial Services and Leasing Activities. The Financial Services segment provides financial structuring services and investment products to clients. The Leasing Activities segment provides rental and residential property services. The company is headquartered in Sydney, Australia.

Qenos Pty Ltd. is an Australian company that manufactures plastic products. The company is based in Altona, Australia. The company is ultimately controlled by the Government of China. Qenos was acquired by China National Chemical Corp., Ltd. from Exxon Mobil Corp. on April 03, 2006.

Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions.

Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia.

International School of Beijing engages in the education services. It runs, operates and manages educational institution and international school. The company was founded in 1980 and is headquartered in Beijing, China.

Walterturnbull Pty Ltd. provides corporate services such as assurance, governance and consulting services. The company was founded by Mark Peatey and is headquartered in Barton, Australia.

Lamellar Biomedical Ltd. manufactures basic pharmaceutical products. The firm's offers lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. The company was founded in 2006 and is headquartered in Bellshill, the United Kingdom.

Steiner Beauty Products, Inc. manufactures and wholesales beauty products. The company was founded in 1990 and is headquartered in Lambertville, NJ.

Merchiston Castle School is a non-profit organization, which operates a boarding and day school for boys. It offers education for Juniors, Middle Years, and Sixth Form. The company is headquartered in Edinburgh, the United Kingdom.

Part of Elanco Animal Health, Inc., ChemGen Corp. develops feed enzyme products that improve the efficiency of poultry, egg, and meat production. The company is based in Gaithersburg, MD. ChemGen was acquired by Elanco Animal Health, Inc. on February 17, 2012 for $206.90 million.

Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark.

The Scottish Lifesciences Association operates an association for life sciences companies and organizations.

Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019.

Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012.

LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD.

Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.

Part of Seraxis Pte Ltd., Seraxis, Inc. is a biotechnology company that specializes in developing a proprietary human stem cell line, sr1423, and manufacturing process to generate pancreatic islets that mimic native islets in purity and potency. The company is based in Germantown, MD. The company has also developed the seragraft device and other tools to enable survival and function of the islet replacement therapy in immunocompetent hosts. Seraxis aims to be the first to provide diabetics a clinical solution for glucose control and complete autonomy from insulin injections. The company was founded in 2013 by William L. Rust, who has been the CEO since 2013.

Seraxis Holdings, Inc. functions as an investment holding private company. The company is based in Germantown, MD. The CEO of the company is William L Rust.